These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis. Saito R, Nonaka S, Fujinami Y, Matsuoka S, Nakajima S, Nishiyama H, Okamura N. J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416 [Abstract] [Full Text] [Related]
9. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital. Yamada K, Arai K, Saito R. J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435 [Abstract] [Full Text] [Related]
13. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis. Köseoglu O, Ergin A, Hascelik G. Scand J Infect Dis; 2004 Jun; 36(6-7):431-4. PubMed ID: 15307563 [Abstract] [Full Text] [Related]
14. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults. Khan MA, Northwood JB, Levy F, Verhaegh SJ, Farrell DJ, Van Belkum A, Hays JP. J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789 [Abstract] [Full Text] [Related]
16. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children]. Köseoğlu O, Ergin A, Gürkan Aydin N, Hasçelik G. Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658 [Abstract] [Full Text] [Related]